Document is current

Any future updates will be listed below

Nilotinib vs. imatinib in Japanese patients with newly diagnosed chronic myeloid leukemia in chronic phase: 10-year follow‑up of the Japanese subgroup of the randomized ENESTnd trial

Crossref DOI link: https://doi.org/10.1007/s12185-021-03216-5

Published Online: 2021-09-11

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark